海辰药业: 独立董事提名人声明与承诺-陆涛

Group 1 - The nominee, Lu Tao, has been proposed as a candidate for the independent director of Nanjing Haichen Pharmaceutical Co., Ltd.'s fifth board of directors [1] - The nomination was made after a thorough understanding of the nominee's professional background, education, qualifications, work experience, and any significant dishonesty records [1] - The nominee has agreed in writing to serve as an independent director candidate [1] Group 2 - The nominee has passed the qualification review by the nomination committee or a special meeting of independent directors [2] - There are no conflicts of interest or other relationships that may affect the nominee's independent performance [2] - The nominee meets the qualifications and independence requirements set forth by relevant laws and regulations [2][3] Group 3 - The nominee has participated in training and obtained relevant certification recognized by the stock exchange [5] - The nominee's appointment as an independent director will not violate the relevant provisions of the Civil Servant Law of the People's Republic of China [5] - The nominee does not have any disqualifying conditions as per the Company Law of the People's Republic of China [2][5] Group 4 - The nominee has the necessary knowledge of the operation of listed companies and relevant laws and regulations, with at least five years of relevant work experience [5] - The nominee and their immediate family members do not hold positions in the company or its subsidiaries [6] - The nominee is not a direct or indirect shareholder holding more than 1% of the company's issued shares [6][7] Group 5 - The nominee has not been subject to any disqualifying actions by the China Securities Regulatory Commission [8] - The nominee has not been penalized for securities-related crimes in the last 36 months [8] - The nominee has not been publicly criticized by the stock exchange three times or more in the last 36 months [9]